Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esteban, V.
Right arrow Articles by Ruiz-Ortega, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esteban, V.
Right arrow Articles by Ruiz-Ortega, M.
J Am Soc Nephrol 15:1514-1529, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Angiotensin II, via AT1 and AT2 Receptors and NF-{kappa}B Pathway, Regulates the Inflammatory Response in Unilateral Ureteral Obstruction

Vanesa Esteban*, Oscar Lorenzo*, Mónica Rupérez*, Yusuke Suzuki{dagger}, Sergio Mezzano{ddagger}, Julia Blanco§, Mathias Kretzler||, Takeshi Sugaya{dagger}, Jesús Egido* and Marta Ruiz-Ortega*

*Vascular and Renal Research Laboratory, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain; {dagger}Division of Nephrology, Juntendo University, Japan; {ddagger}Division of Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile; §Hospital Clínico de San Carlos, Madrid, Spain; and ||Nephrology Center, University of Munich, Munich, Germany

Correspondence to Dr. Marta Ruiz-Ortega, Vascular and Renal Research Laboratory, Fundación Jiménez Díaz, Avda Reyes Católicos, 2, 28040 Madrid, Spain. Phone: 34-91-550-48-00, ext 3168; Fax: 34-91-5442636; E-mail: mruizo{at}fjd.es

ABSTRACT. Inflammatory cell infiltration plays a key role in the onset and progression of renal injury. The NF-{kappa}B participates in the inflammatory response, regulating many proinflammatory genes. Angiotensin II (Ang II), via AT1 and AT2 receptors, activates NF-{kappa}B. Although the contribution of Ang II to kidney damage progression is already established, the receptor subtype involved in the inflammatory cell recruitment is not clear. For investigating this issue, the unilateral ureteral obstruction (UUO) model was used in mice, blocking Ang II production/receptors and NF-{kappa}B pathway. Two days after UUO, obstructed kidneys of wild-type mice presented a marked interstitial inflammatory cell infiltration and increased NF-{kappa}B activity. Treatment with AT1 or AT2 antagonists partially decreased NF-{kappa}B activation, whereas only the AT2 blockade diminished monocyte infiltration. Obstructed kidneys of AT1-knockout mice showed interstitial monocyte infiltration and NF-{kappa}B activation; both processes were abolished by an AT2 antagonist, suggesting AT2/NF-{kappa}B involvement in monocyte recruitment. In wild-type mice, only angiotensin-converting enzyme inhibition or combined therapy with AT1 plus AT2 antagonists blocked monocyte infiltration, NF-{kappa}B activation, and upregulation of NF-{kappa}B–related proinflammatory genes. Therefore, AT1 and AT2 blockade is necessary to arrest completely the inflammatory process. Treatment with two different NF-{kappa}B inhibitors, pirrolidin-dithiocarbamate and parthenolide, diminished monocyte infiltration and gene overexpression. These data show that Ang II, via AT1 and AT2 receptors and NF-{kappa}B pathway, participates in the regulation of renal monocyte recruitment and may provide a rationale to investigate further the role of AT2 in human kidney diseases.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. de Seigneux, V. Leroy, H. Ghzili, M. Rousselot, S. Nielsen, B. C. Rossier, P.-Y. Martin, and E. Feraille
NF-{kappa}B Inhibits Sodium Transport via Down-regulation of SGK1 in Renal Collecting Duct Principal Cells
J. Biol. Chem., September 12, 2008; 283(37): 25671 - 25681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Shweke, N. Boulos, C. Jouanneau, S. Vandermeersch, G. Melino, J.-C. Dussaule, C. Chatziantoniou, P. Ronco, and J.-J. Boffa
Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-{beta} Activation and Cell Infiltration
Am. J. Pathol., September 1, 2008; 173(3): 631 - 642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. V. Durvasula and S. J. Shankland
Activation of a local renin angiotensin system in podocytes by glucose
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F830 - F839.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy
Physiol Genomics, October 19, 2007; 31(2): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Chen, A. M. Guo, P. A. Edwards, G. Trick, and A. G. Scicli
Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1619 - R1629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Coleman, J. J. Minor, L. E. Burt, B. A. Thornhill, M. S. Forbes, and R. L. Chevalier
Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F262 - F268.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J.-S. Jerng, Y.-C. Hsu, H.-D. Wu, H.-Z. Pan, H.-C. Wang, C.-T. Shun, C.-J. Yu, and P.-C. Yang
Role of the renin-angiotensin system in ventilator-induced lung injury: an in vivo study in a rat model
Thorax, June 1, 2007; 62(6): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Tone, K. Shikata, D. Ogawa, S. Sasaki, R. Nagase, M. Sasaki, K. Yozai, H. Kataoka Usui, S. Okada, J. Wada, et al.
Changes of gene expression profiles in macrophages stimulated by angiotensin II -- Angiotensin II induces MCP-2 through AT1-receptor
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 45 - 50.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Yu, R. Gong, A. Rifai, E. M. Tolbert, and L. D. Dworkin
Long-Term, High-Dosage Candesartan Suppresses Inflammation and Injury in Chronic Kidney Disease: Nonhemodynamic Renal Protection
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 750 - 759.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. D. Hewitson, I. Mookerjee, R. Masterson, C. Zhao, G. W. Tregear, G. J. Becker, and C. S. Samuel
Endogenous Relaxin Is a Naturally Occurring Modulator of Experimental Renal Tubulointerstitial Fibrosis
Endocrinology, February 1, 2007; 148(2): 660 - 669.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. O. Topcu, M. Pedersen, R. Norregaard, G. Wang, M. Knepper, J. C. Djurhuus, S. Nielsen, T. M. Jorgensen, and J. Frokiaer
Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F736 - F748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. K. Fujihara, G. R. Antunes, A. L. Mattar, D. M. A. C. Malheiros, J. M. Vieira Jr., and R. Zatz
Chronic inhibition of nuclear factor-{kappa}B attenuates renal injury in the 5/6 renal ablation model
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F92 - F99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Ozawa, H. Kobori, Y. Suzaki, and L. G. Navar
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F330 - F339.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Fernandez-Juarez, V. Barrio, S. G. de Vinuesa, M. Goicoechea, M. Praga, and J. Luno
Dual Blockade of the Renin-Angiotensin System in the Progression of Renal Disease: The Need for More Clinical Trials
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S250 - S254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Okada, T. Inoue, T. Kikuta, Y. Watanabe, Y. Kanno, S. Ban, T. Sugaya, M. Horiuchi, and H. Suzuki
A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade
Am. J. Pathol., November 1, 2006; 169(5): 1577 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Ortega, D. Ramila, J. A. Ardura, V. Esteban, M. Ruiz-Ortega, A. Barat, R. Gazapo, R. J. Bosch, and P. Esbrit
Role of Parathyroid Hormone-Related Protein in Tubulointerstitial Apoptosis and Fibrosis after Folic Acid-Induced Nephrotoxicity
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1594 - 1603.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Ruiz-Ortega, M. Ruperez, V. Esteban, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 16 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S.-L. Lin, R.-H. Chen, Y.-M. Chen, W.-C. Chiang, C.-F. Lai, K.-D. Wu, and T.-J. Tsai
Pentoxifylline Attenuates Tubulointerstitial Fibrosis by Blocking Smad3/4-Activated Transcription and Profibrogenic Effects of Connective Tissue Growth Factor
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2702 - 2713.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Zhang, Y. Ma, J. Zhang, J. Cheng, and J. Du
A New Cellular Signaling Mechanism for Angiotensin II Activation of NF-{kappa}B: An I{kappa}B-Independent, RSK-Mediated Phosphorylation of p65
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1148 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Esteban, M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, O. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, and M. Ruiz-Ortega
Angiotensin IV Activates the Nuclear Transcription Factor-{kappa}B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells
Circ. Res., May 13, 2005; 96(9): 965 - 973.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Gong, A. Rifai, E. M. Tolbert, P. Biswas, J. N. Centracchio, and L. D. Dworkin
Hepatocyte Growth Factor Ameliorates Renal Interstitial Inflammation in Rat Remnant Kidney by Modulating Tubular Expression of Macrophage Chemoattractant Protein-1 and RANTES
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2868 - 2881.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP